TUMOR INFILTRATING LYMPHOCYTES AND PROGRAMMED DEATH LIGAND 1 (PD-L1) EXPRESSION IN DIFFUSE AND ANAPLASTIC GLIOMAS

被引：0
|
作者：
Berghoff, A. S. [1 ]
Kiesel, B. [2 ]
Widhalm, G. [2 ]
Wilhelm, D. [1 ]
Rajky, O. [1 ]
Kurscheid, S. [3 ]
Hegi, M. [4 ]
Woehrer, A. [5 ]
Marosi, C. [1 ]
Preusser, M. [1 ]
机构：
[1] Med Univ Vienna, Dept Med, Vienna, Austria
[2] Med Univ Vienna, Dept Neurosurg, Vienna, Austria
[3] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Sci, Canberra, ACT, Australia
[4] Univ Lausanne Hosp, Dept Clin Neurosci, Serv Neurosurg, Lab Brain Tumor Biol & Genet, Lausanne, Swaziland
[5] Med Univ Vienna, Inst Neurol, Vienna, Austria
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P04.09
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [41] Prognostic Impact of Tumor Microenvironment in Carcinosarcoma of the Female Genital Tract: A Study of CD8+Tumor Infiltrating Lymphocytes and Programmed Death-Ligand 1 (PD-L1) Expression
    Amezcua, Jose Manuel Gutierrez
    Ordner, Jeffrey
    Shukla, Pratibha
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 690 - 691
  • [42] Prognostic Impact of Tumor Microenvironment in Carcinosarcoma of the Female Genital Tract: A Study of CD8+Tumor Infiltrating Lymphocytes and Programmed Death-Ligand 1 (PD-L1) Expression
    Amezcua, Jose Manuel Gutierrez
    Ordner, Jeffrey
    Shukla, Pratibha
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 690 - 691
  • [43] PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma
    Cao, Jinfeng
    Brouwer, Niels J.
    Richards, Kate E.
    Marinkovic, Marina
    van Duinen, Sjoerd
    Hurkmans, Daan
    Verdegaal, Els M. E.
    Jordanova, Ekaterina S.
    Jager, Martine J.
    ONCOTARGET, 2017, 8 (33) : 54722 - 54734
  • [44] Expression of PD-L1 and PD-1 Positive Tumor Infiltrating Lymphocytes in Ovarian Tumors
    Bonneau, Peter N.
    Carrillo, Luis F.
    Mackinnon, Alexander C.
    LABORATORY INVESTIGATION, 2016, 96 : 277A - 277A
  • [45] Expression of PD-L1 and PD-1 Positive Tumor Infiltrating Lymphocytes in Ovarian Tumors
    Bonneau, Peter N.
    Carrillo, Luis F.
    Mackinnon, Alexander C.
    MODERN PATHOLOGY, 2016, 29 : 277A - 277A
  • [46] Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma
    Nam, Soo Jeong
    Kim, Young-Hoon
    Park, Ji Eun
    Ra, Young-shin
    Khang, Shin Kwang
    Cho, Young Hyun
    Kim, Jeong Hoon
    Sung, Chang Ohk
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (02) : 305 - 318
  • [47] Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma
    Soo Jeong Nam
    Young-Hoon Kim
    Ji Eun Park
    Young-shin Ra
    Shin Kwang Khang
    Young Hyun Cho
    Jeong Hoon Kim
    Chang Ohk Sung
    Cancer Immunology, Immunotherapy, 2019, 68 : 305 - 318
  • [48] Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas
    Coffey, Amy M.
    Curry, Jonathan L.
    Marcogliese, Andrea N.
    Tetzlaff, Michael T.
    Kamdar, Kala
    Elghetany, Mohamed T.
    Curry, Choladda V.
    LABORATORY INVESTIGATION, 2017, 97 : 344A - 344A
  • [49] Predictive value of tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer patients treated with neoadjuvant chemotherapy
    Rashed, Hayam E.
    Muhammad, Shireen S.
    Sameh, Reham
    Elsebai, Eman
    Nawar, Nashwa
    Abdelhamid, Mohamed I.
    Abdelaziz, Lobna A.
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2021, 34 (04): : 200 - 207
  • [50] Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas
    Coffey, Amy M.
    Curry, Jonathan L.
    Marcogliese, Andrea N.
    Tetzlaff, Michael T.
    Kamdar, Kala
    Elghetany, Mohamed T.
    Curry, Choladda V.
    MODERN PATHOLOGY, 2017, 30 : 344A - 344A
12345